Kali-Extracts Explores $50 Million Cannabis Biopharmaceutical Technology Sale

Cannabis Business Times
Oct 31, 2019, 2:11 pm345 pts
DALLAS, Oct. 31, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- PRESS RELEASE -- Kali-Extracts, Inc. (USOTC: KALY) has announced taking a next step with the investor that has recently valued KALY’s biopharmaceutical technology at $50 million. The valuation has been presented to KALY by an investor interested in…

Read Article Share
Share Article
- email
- twitter
- facebook
- pocket
- reddit
- tumblr
- linkedin
- pinterest

Trending Today on NewsBudz

Arkansas Medical Marijuana Sales Are On Track To Set A New Annual Record 49

About NewsBudz

NewsBudz is your go-to app for daily cannabis news, covering everything from medical marijuana breakthroughs to recreational cannabis trends and legalization updates.

Our platform aggregates content from over 30 top-tier cannabis news outlets to deliver a curated stream of the latest headlines, insights, and developments across the marijuana and hemp industries.

Whether you're interested in policy reform, health research, cannabis business, CBD, delta 9 products or lifestyle stories, NewsBudz keeps you informed and connected. Accessible on the web and mobile, NewsBudz makes it easy to explore, read, and share cannabis news anytime, anywhere.